Myriad Genetics | MYGN - Net Income


Myriad Genetics reported $-7.9M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Bruker USD 26M 88.4M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Illumina USD 334M 184M Dec/2025
J&J USD 5.24B 119M Mar/2026
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Quidel USD -733M 477.6M Sep/2025
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Veracyte USD 41.15M 22.01M Dec/2025
Waters USD 225.21M 76.29M Dec/2025